Elevation of serum level of vascular endothelial growth factor as a new predictor of recurrence and disease progression in patients with superficial urothelial cancer
- 1 February 1999
- Vol. 53 (2) , 302-307
- https://doi.org/10.1016/s0090-4295(98)00486-5
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Basic Fibroblast Growth Factor Regulates Matrix Metalloproteinases Production and In Vitro Invasiveness in Human Bladder Cancer Cell LinesJournal of Urology, 1997
- Expression of platelet-derived endothelial cell growth factor in bladder carcinomaCancer, 1997
- Prognostic variables in patients with upper urinary tract cancersInternational Journal of Clinical Oncology, 1996
- Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinomaBritish Journal of Cancer, 1996
- Enhancement of Tumor Growth and Vascular Density by Transfection of Vascular Endothelial Cell Growth Factor Into MCF-7 Human Breast Carcinoma CellsJNCI Journal of the National Cancer Institute, 1995
- Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancerHuman Pathology, 1995
- Quantification of angiongenesis as an independent predictor of prognosis in invasive bladder carcinomasBritish Journal of Urology, 1994
- Increased Immunodetection of Acidic Fibroblast Growth Factor in Bladder Cancer, Detectable in UrineJournal of Urology, 1993
- Vascular permeability factor (VPF, VEGF) in tumor biologyCancer and Metastasis Reviews, 1993
- Elevated Levels of the Angiogenic Peptide Basic Fibroblast Growth Factor in Urine of Bladder Cancer PatientsJNCI Journal of the National Cancer Institute, 1993